CAIX over-expression in cancer cells has also been extensively analyzed in patients with head and neck SCCs but its over-expression has been mostly associated with poor prognosis in patients that received radiotherapy and/or chemoradiotherapy [42–44]. The gene discussed is CA9; the disease is cancer.